Clinical Trial Update: Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating thalidomide, cyclophosphamide, and dexamethasone for recurrent/refractory adult Langerhans Cell Histiocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Langerhans Cell Histiocytosis | Phase 2 | Status: UNKNOWN